Stock listing

NASDAQ:CNST Constellation Pharmaceuticals Inc Stock

Follow Constellation Pharmaceuticals Inc into a list and get an email when it puts out news.

Last close · NASDAQ:CNST

$33.99 USD

Close on Jul 15, 2021 · No longer trades

Jul 19, 2018 to last close +195.6% · weekly closes, Jul 19, 2018 – Jul 15, 2021
Lowest – highest close
$4.01 – $49.79 USDSince Jul 19, 2018 · lowest Dec 31, 2018 · highest May 12, 2020

Delisted NASDAQ:CNST no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:CNST
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Constellation Pharmaceuticals Inc on 6ix

Decks
12 decks · latest Jan 13, 2020

Decks

DeckKindSlidesDate
J.P. Morgan Healthcare Conference 2020Conference27 slidesJan 13, 2020
Investor Presentation (September 2019)Investor deck45 slidesSep 24, 2019
Investor Presentation (August 2019)Investor deck46 slidesAug 7, 2019
Investor Presentation (May 2019)Investor deck39 slidesMay 16, 2019
Investor Presentation (May 2019)Investor deck38 slidesMay 8, 2019
Investor Presentation (April 2019)Investor deck40 slidesApr 1, 2019
Investor Presentation (March 2019)Investor deck37 slidesMar 14, 2019
Investor Presentation (January 2019)Investor deck39 slidesJan 7, 2019
Investor Presentation (December 2018)Investor deck37 slidesDec 10, 2018
Investor Presentation (November 2018)Investor deck40 slidesNov 9, 2018
All 12 decks
DeckKindSlidesDate
Investor Presentation (October 2018)Investor deck41 slidesOct 11, 2018
Investor Presentation (August 2018)Investor deck41 slidesAug 14, 2018

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Richard Levy
Other companies: Protara Therapeutics, Inc. (Director · Since at least Jan 9, 2020); Kiniksa Pharmaceuticals International, plc (Director · Since at least Mar 4, 2019); Kodiak Sciences Inc (Director · Since at least Oct 3, 2018); Madrigal Pharmaceuticals, Inc. (Director · Since at least Jun 19, 2018)
Director · Apr 3, 2020 – Jul 15, 2021 · Past
Jeffrey Humphrey
Other companies: Lantheus Holdings, Inc. (Chief Medical Officer · May 28, 2024 – Jun 17, 2024 · Past); Cyteir Therapeutics Inc (Director · Dec 15, 2021 – Feb 3, 2023 · Past); Dianthus Therapeutics, Inc. (Chief Medical Officer · Oct 1, 2021 – Aug 1, 2022 · Past)
Chief Medical Officer · Jun 22, 2020 – Jul 15, 2021 · Past
Mark A. Goldsmith
Other companies: Revolution Medicines, Inc. (President, Chief Executive Officer and Board Chairman · Since at least Feb 12, 2020)
Director · Jul 18, 2018 – Jul 15, 2021 · Past

Open People

Log in to ask 6ix AI your own questions about Constellation Pharmaceuticals Inc.